Advertisement

Picture EBD Group ChinaBio Partnerting Forum 2021 651x80

News > All

Total search results: 4648 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 18 19 20 ... 45 46 47  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Probiodrug AG. (10/5/18). "Press Release: Probiodrug Reports Management Changes". Halle (Saale). 2018-10-05
Bluebird Bio, Inc.. (10/5/18). "Press Release: Bluebird Bio Announces European Medicines Agency’s Acceptance of Marketing Authorization Application for LentiGlobin Gene Therapy for the Treatment of Transfusion-Dependent ß-Thalassemia". Cambridge, MA. 2018-10-05
Apceth Biopharma GmbH. (10/5/18). "Press Release: Apceth to Manufacture First Potential One-time Gene Therapy for Transfusion Dependent ß-Thalassemia". Munich. 2018-10-05
ERS Genomics Ltd.. (10/4/18). "Press Release: Axcelead Drug Discovery Partners and ERS Genomics Enter into CRISPR/Cas9 License Agreement". Fujisawa & Dublin. 2018-10-04
ERS Genomics Ltd.. (10/4/18). "Press Release: GenAhead Bio and ERS Genomics Enter into CRISPR/Cas9 License Agreement". Fujisawa & Dublin. 2018-10-04
Evotec AG. (10/4/18). "Press Release: Evotec Signs Agreement with Sanofi to Advance Early Stage Academic Research into Novel Therapeutic Candidates". Hamburg. 2018-10-04
Evotec AG. (10/4/18). "Press Release: LAB150 Awards Its Second Drug Discovery Project from Canada’s Largest Research-based Hospital, The University Health Network (UHN)". Toronto. 2018-10-04
GO Therapeutics, Inc.. (10/2/18). "Press Release: GO Therapeutics Enters into a License Agreement with Roche for New Glycotargeting Bispecific Cancer Treatment". Cambridge, MA. 2018-10-02
Curetis N.V.. (10/2/18). "Press Release: Curetis Secures Financing Facility of up to EUR 20 Million through the Issuance of Convertible Notes". Amsterdam, Holzgerlingen & San Diego, CA. 2018-10-02
Genedata AG. (10/2/18). "Press Release: Genedata Bioprocess Offers Out-of-the-Box Integration with ambr Bioreactors". Basel. 2018-10-02
Oncgnostics GmbH. (10/2/18). "Press Release: Oncgnostics GmbH Retains Biotech Alliances International Inc. to Support Global Partnering and Distribution Strategy". San Francisco, CA & Jena. 2018-10-02
Taros Chemicals GmbH & Co. KG. (10/1/18). "Press Release: Taros Appoints Torsten Hoffmann as Senior Vice President Drug Discovery". Dortmund. 2018-10-01
AiCuris Anti-infective Cures GmbH. (10/1/18). "Press Release: AiCuris to Cooperate with Cyclenium Pharma to Develop Novel Anti-Infectives". Wuppertal & Montreal. 2018-10-01
Forbion Capital Partners. (10/1/18). "Press Release: Forbion Closes Oversubscribed Fourth Life Sciences VC Fund at EUR 360 Million". Naarden & Munich. 2018-10-01
CeGaT GmbH. (10/1/18). "Press Release: Personalized Cancer Therapy. B. Braun and CeGaT Found Joint Venture CeCaVa". Melsungen & Tübingen. 2018-10-01
Biotechpharma UAB. (10/1/18). "Press Release: Biotechpharma UAB Appoints Frank Ternes as Chief Business Officer". 2018-10-01
Tusk Therapeutics Ltd.. (9/28/18). "Press Release: Tusk Therapeutics to Be Acquired by Roche". Stevenage. 2018-09-28
Qiagen N.V.. (9/28/18). "Press Release: Qiagen Receives FDA Approval to Expand Use of EGFR Test in Lung Cancer". Germantown, MD & Hilden. 2018-09-28
MVZ Labor Dr. Limbach & Kollegen. (9/28/18). "Pressemitteilung: Molekulargenetisches Labor erweitert das Spektrum des MVZ Labor Dr. Limbach & Kollegen". 2018-09-28
Mologen AG. (9/27/18). "Press Release: Mologen AG Completes Capital Increase with Gross Proceeds of around EUR8 Million [NOT FOR RELEASE IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, et al.]". Berlin. 2018-09-27
Valneva S.E.. (9/27/18). "Press Release: Valneva Raises €50 Million in Oversubscribed Placement Led by US Healthcare Investors [Not for Distribution in the United States, Canada, Australia or Japan]". Saint-Herblain. 2018-09-27
Genedata AG. (9/27/18). "Press Release: Bayer Partners with Genedata to Digitalize Crop Science Research and Development". Basel. 2018-09-27
Inova Software S.A.S.. (9/27/18). "Press Release: Inova Software Secures Additional Funding from Its Founders and NextStage AM to Support Its Strong Growth". New York, NY. 2018-09-27
BCNP Consultants GmbH. (9/26/18). "Press Release: Over 600 Partnering Discussions at the First European Chemistry Partnering Summer Summit". Düsseldorf. 2018-09-26
Minoryx Therapeutics S.L.. (9/26/18). "Press Release: Minoryx Therapeutics Raises €21.3M in Series B Funding Round". Mataró, Barcelona. 2018-09-26
SGS S.A.. (9/26/18). "Press Release: SGS Issues CHF 225 Million and CHF 175 Million Bonds [NOT FOR DISTRIBUTION IN THE UNITED STATES et al.]". 2018-09-26
Brooks Automation, Inc.. (9/26/18). "Press Release: Brooks Automation Announces the Acquisition of Genewiz Group". Chelmsford, MA. 2018-09-26
Valneva S.E.. (9/26/18). "Press Release: Valneva Launches a Capital Increase of Approximately €40 Million [Not for Distribution in the United States, Canada, Australia or Japan]". Saint-Herblain. 2018-09-26
Celyad S.A.. (9/26/18). "Press Release: Celyad Appoints Carri Duncan as Vice-President Corporate Development and Communications". Mont-Saint-Guibert. 2018-09-26
Myelo Therapeutics GmbH. (9/25/18). "Press Release: FDA Grants Myelo Therapeutics Orphan Drug Designation for Myelo001 as Treatment for Acute Radiation Syndrome". Berlin. 2018-09-25
Aktiia S.A.. (9/25/18). "Press Release: Aktiia Closes 4M Seed Round to Reinvent Blood Pressure Monitoring". Neuchâtel. 2018-09-25
Protagen AG. (9/25/18). "Press Release: NEC Laboratories Europe GmbH, the National Center for Tumor Diseases and Protagen AG Collaborate to Improve Information Integration and Artificial Intelligence for Better Therapy Decisions in Immuno-Oncology". 2018-09-25
MaxiVax S.A.. (9/25/18). "Press Release: MaxiVax Starts Phase 2 Study in Switzerland of Innovative Cancer Vaccine in Patients with Head & Neck Cancer". Geneva. 2018-09-25
PathoQuest S.A.S.. (9/25/18). "Press Release: PathoQuest Names Dr. Christiane Honisch to Board of Directors". Paris. 2018-09-25
Thermo Fisher Scientific Inc.. (9/24/18). "Press Release: New Single Quadrupole Mass Spectrometry Technology Designed for Chromatographers Performing LC-MS Routine Analysis". Cannes-Mandelieu. 2018-09-24
Tolremo Therapeutics AG. (9/24/18). "Press Release: Tolremo Raises CHF 9 Million Series A Financing Round and Strengthens Board of Directors with Industry Experts". Zurich. 2018-09-24
Sophia Genetics S.A.. (9/24/18). "Press Release: Sophia Genetics Sets Up Headquarters in Boston to Meet Growing Demand in the U.S.". Durham, NC. 2018-09-24
InflaRx N.V.. (9/21/18). "Press Release: InflaRx N.V. Announces Appointment of Jens Holstein to Board of Directors". Jena. 2018-09-21
Thermo Fisher Scientific Inc.. (9/20/18). "Press Release: Thermo Fisher Scientific to Launch Global Customer Solution Centers". Waltham, MA. 2018-09-20
4SC AG. (9/20/18). "Press Release: Domatinostat Plus Chemotherapy – Overcoming Drug Resistance". Planegg-Martinsried. 2018-09-20
Addex Therapeutics S.A.. (9/20/18). "Press Release: Addex ADX10061 Receives £1.2 million Funding for Manufacture and Investigator Led Clinical Studies as Part of the Tools for Human Drug and Brain Research (THuNDR2) Initiative from the Wellcome Trust". G 2018-09-20
Lonza Group Ltd.. (9/20/18). "Press Release: Lonza Expands Ibex Solutions to Offer Complete Product Lifecycle Management in One Location". Basel. 2018-09-20
Plug and Play LLC. (9/20/18). "Press Release: Plug and Play Launches the First Health-focused Innovation Program in Munich – "Startup Creasphere"". Munich. 2018-09-20
Valneva S.E.. (9/20/18). "Press Release: Valneva Announces Extension of Drawdown Period for Its Existing European Investment Bank Loan". Saint-Herblain. 2018-09-20
Apeiron Biologics AG. (9/19/18). "Press Release: Apeiron Announces Collaboration with Lead Discovery Center GmbH". Vienna. 2018-09-19
CRISPR Therapeutics AG. (9/19/18). "Press Release: CRISPR Therapeutics Announces Proposed Public Offering of Common Shares". Zug & Cambridge, MA. 2018-09-19
Neurimmune AG. (9/18/18). "Press Release: Neurimmune Achieves Milestone in Collaboration with Ono Pharmaceutical". Schlieren. 2018-09-18
GeNeuro S.A.. (9/18/18). "Press Release: GeNeuro Regains Worldwide Rights ex US and Japan to GNbAC1 in Multiple Sclerosis from Servier". Paris & Geneva. 2018-09-18
BRAIN AG. (9/18/18). "Press Release: BRAIN AG Announces Strategic Research Collaboration with BluCon Biotech GmbH". Zwingenberg & Cologne. 2018-09-18
Roche. (9/18/18). "Press Release: Roche’s NAVIFY Decision Support Portfolio Unlocks Relevant Content from Clinical Trial and Medical Publication Databases". Basel. 2018-09-18
Cellectis S.A.. (9/18/18). "Press Release: Calyxt Appoints CEO, Jim Blome, Former President & CEO of Bayer CropScience LP". Minneapolis, MN & New York, NY. 2018-09-18
Evotec AG. (9/17/18). "Press Release: Evotec and Almirall Enter into Research Collaboration in the Field of Dermatiological Diseases". Hamburg & Barcelona. 2018-09-17
Qiagen N.V.. (9/17/18). "Press Release: Qiagen and NeuMoDx Announce Strategic Partnership to Offer Next-generation Systems for Fully Integrated Molecular Diagnostic Testing". Hilden & Ann Arbor, MI. 2018-09-17
Qiagen N.V.. (9/17/18). "Press Release: Qiagen and DiaSorin Launch Automated Testing for Latent TB Infection with QuantiFERON-TB Gold Plus Technology on Widely Used Liaison Platforms". Hilden & Saluggia. 2018-09-17
CRISPR Therapeutics AG. (9/17/18). "Press Release: CRISPR Therapeutics and ViaCyte Announce Strategic Collaboration to Develop Gene-Edited Stem Cell-Derived Therapy for Diabetes". Zug, Cambridge, MA & San Diego, CA. 2018-09-17
BioPhero A/S. (9/157/18). "Press Release: Danish Industrial Biotech Company BioPhero ApS Completes a €3 Million Seed Investment and Appoints New Chairman of the Board". 2018-09-17
Thermo Fisher Scientific Inc.. (9/17/18). "Press Release: New Validated Analytical Workflow for Complex Quantitation of Veterinary Drugs". San José, CA. 2018-09-17
Luciole Medical AG. (9/17/18). "Press Release: Luciole Medical Raises CHF 5.3 Million in Series A Financing for Novel Brain Monitoring Platform". Zürich. 2018-09-17
Bruker Corporation. (9/14/18). "Press Release: Bruker Introduces New High Performance Preclinical PET/CT Si78 System". Seattle, WA. 2018-09-14
ViraTherapeutics GmbH. (9/13/18). "Press Release: Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies". Ingelheim. 2018-09-13
Wacker Chemie AG. (9/13/18). "Press Release: Wacker Invests in Jena Biotech Site". Jena. 2018-09-13
Sanofi S.A.. (9/13/18). "Press Release: Sanofi to Refocus Two Global Business Units". Paris. 2018-09-13
MorphoSys AG. (9/13/18). "Press Release: MorphoSys and Galapagos Announce Start of a Phase 1 Subcutaneous Bridging Study with MOR106". Planegg & Mechelen. 2018-09-13
Neurimmune AG. (9/12/18). "Press Release: Neurimmune Appoints Christoph Hock as Chief Medical Officer to Lead Clinical Development". Schlieren. 2018-09-12
Qiagen N.V.. (9/12/18). "Press Release: Qiagen to Join Germany’s MDAX Index in Addition to TecDAX". Hilden & Germantown, MD. 2018-09-12
Boehringer Ingelheim. (9/12/18). "Press Release: Biosimilar Cyltezo Demonstrates Clinical Equivalence to Humira in Patients with Moderate-to-Severe Plaque Psoriasis". Ingelheim. 2018-09-12
European Commission. (9/11/18). "Press Release: European List of Strategic Research infrastructures Expands into New Areas". Vienna. 2018-09-11
Crescendo Biologics Ltd.. (9/11/18). "Press Release: Crescendo Biologics Strengthens its Management with the Appointment of Dr Pavel Pisa as Chief Medical Officer". Cambridge. 2018-09-11
Definiens AG. (9/10/18). "Press Release: Definiens Embarks on Digital Pathology Collaboration with Merck's Exploratory and Clinical Development Programs". Munich. 2018-09-10
Pieris Pharmaceuticals, Inc.. (9/10/18). "Press Release: Pieris Pharmaceuticals Appoints Peter Kiener, D.Phil., to its Board of Directors". Boston, MA. 2018-09-10
RSP Systems A/S. (9/10/18). "Press Release: RSP Systems Adds EUR 3.85 Million in a Second Closing of its Series B Funding Round, Increasing the Round Total to EUR 10.35 Million". Odense. 2018-09-10
Haplogen Bioscience GmbH. (9/10/18). "Press Release: Cyclenium Pharma and Haplogen Bioscience Announce Granting of EUREKA Label and Funding to Develop Novel Therapies in Severe Viral Diseases". Montréal, QC & Vienna. 2018-09-10
Lunaphore Technologies S.A.. (9/9/18). "Press Release: Menarini Will Bring Lunaphore’s Ultra-Rapid Tissue Staining Solution LabSat Frozen to Market". Lausanne & Florence. 2018-09-09
Evotec AG. (9/6/18). "Press Release: Evotec and Celgene Enter Partnership in the Field of Targeted Protein Degradation". Hamburg. 2018-09-06
Evotec AG. (9/6/18). "Press Release: Evotec AG Listed in MDAX". Hamburg. 2018-09-06
MorphoSys AG. (9/6/18). "Press Release: MorphoSys AG to Be Listed in MDAX". Planegg. 2018-09-06
Medigene AG. (9/6/18). "Press Release: Medigene Announces Inclusion in SDAX". Planegg. 2018-09-06
Novartis AG. (9/6/18). "Press Release: Novartis to Divest the Sandoz US Dermatology Business and Generic US Oral Solids Portfolio to Aurobindo". Basel. 2018-09-06
Polyphor Ltd.. (9/6/18). "Press Release: Novo Holdings Invests CHF 6.8 Million in Polyphor to Accelerate the Development of Novel Antibiotics against Multi-drug Resistant Gram-negative Pathogens". Allschwil & Copenhagen. 2018-09-06
Polyphor Ltd.. (9/6/18). "Press Release: Polyphor Announces Financial Results for the First Half 2018". Allschwil. 2018-09-06
Twentyeight-Seven. (9/6/18). "Press Release: Twentyeight-Seven Therapeutics Launches with a $65 Million Series A Funding". Cambridge, MA. 2018-09-06
Adocia S.A.. (9/5/18). "Press Release: Adocia Announces Positive Topline Results for the First Clinical Study of BioChaperone Pramlintide Insulin in People with Type 1 Diabetes". Lyon. 2018-09-05
Minoryx Therapeutics S.L.. (9/5/18). "Press Release: Minoryx Therapeutics Announces Dosing of First US Patient in Phase 2/3 Clinical study of MIN-102 (ADVANCE)". Mataró, Barcelona. 2018-09-05
Creoptix AG. (9/5/18). "Press Release: Creoptix Attracts Waters as Corporate Investor". Wädenswil (Zurich). 2018-09-05
Probiodrug AG. (9/4/18). "Press Release: Probiodrug Appoints Dr. Michael Schaeffer as Executive Vice President of Business and Strategy". Halle (Saale). 2018-09-04
Miracor Medical S.A.. (9/4/18). "Press Release: Miracor Medical Closes Final Tranche of Series D, Bringing the Round to €30M". Awans. 2018-09-04
Abivax S.A.. (9/4/18). "Press Release: Abivax Reports Impressive Results in Clinical Phase 2a Trial of ABX464 as an Oral Treatment for Ulcerative Colitis Patients". Paris. 2018-09-04
Pieris Pharmaceuticals, Inc.. (9/4/18). "Press Release: Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Combination Trial for PRS-343 Plus Anti-PD-L1 Immunotherapy". Boston, MA. 2018-09-04
NTrans Technologies B.V.. (9/4/18). "Press Release: NTrans Technologies Receives Horizon 2020 SME Grant". 2018-09-04
EuropaBio. (9/3/18). "Press Release: EuropaBio Appoints New Secretary General, Healthcare Director and Industrial Biotech Director". Brussels. 2018-09-03
AiCuris Anti-infective Cures GmbH. (9/3/18). "Press Release: AiCuris Reports Positive Phase 1 Clinical Trial Results with Immunomodulator AIC649 in Patients with Chronic Hepatitis B". Wuppertal. 2018-09-03
Tecan Group Ltd.. (9/3/18). "Press Release: Tecan Successfully Completes the Acquisition of NuGen Technologies". Männedorf. 2018-09-03
Sanofi S.A.. (9/3/18). "Press Release: Cablivi (caplacizumab) Approved in Europe for Adults with Acquired Thrombotic Thrombocytopenic Purpura (aTTP)". Paris. 2018-09-03
Boehringer Ingelheim. (9/3/18). "Press Release: Boehringer Ingelheim Biopharmaceuticals China Supports BeiGene in Its China NDA Submission of anti-PD-1 Antibody, Tislelizumab". Shanghai. 2018-09-03
Medigene AG. (8/31/18). "Press Release: Medigene Announces Change in Executive Leadership Team". Planegg. 2018-08-31
Novartis Pharma GmbH. (8/31/18). "Pressemitteilung: Novartis und das Fraunhofer IZI geben Kooperation in der CAR-T Zelltherapie für Patienten in Europa bekannt". Leipzig & Nürnberg. 2018-08-31
BRAIN AG. (8/31/18). "Press Release: BRAIN AG Reports Growth for the First Nine Months of the 2017/18 Financial Year". Zwingenberg. 2018-08-31
EMD Serono. (8/31/18). "Press Release: Rehan Verjee to Lead EMD Serono as Company Advances its Innovative Medicines Strategy in North America". Rockland, MA. 2018-08-31
Lunaphore Technologies S.A.. (8/30/18). "Press Release: Lunaphore Closes a CHF 5.3M Series B Financing Round". Lausanne. 2018-08-30
Evotec AG. (8/30/18). "Press Release: Evotec and CHDI Foundation Extend Ongoing Collaboration to Fight Huntington’s Disease". Hamburg. 2018-08-30
next pagenext page 1 2 3 ... 18 19 20 ... 45 46 47  next pagenext page



Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group BIO-Europe Spring 2021 Digital 650x80

» top